title: Extended half-life factor VIII for immune tolerance induction in haemophilia.
authors.affiliation: University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.|Hemophilia Center of Western Pennsylvania, Pittsburgh, PA, USA.
authors.forename: L M
authors.initials: LM
authors.lastname: Malec
authors.affiliation: University of Texas Southwestern School of Medicine, Dallas, TX, USA.|Bleeding Disorder and Thrombosis, Program Pauline Allen Gill Center for Cancer and Blood Disorders, Dallas, TX, USA.
authors.forename: J
authors.initials: J
authors.lastname: Journeycake
authors.affiliation: University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.|Hemophilia Center of Western Pennsylvania, Pittsburgh, PA, USA.
authors.forename: M V
authors.initials: MV
authors.lastname: Ragni
mesh_terms: D002648:Child; D005169:Factor VIII / Q000008:administration & dosage* / Q000276:immunology / Q000493:pharmacokinetics*; D005260:Female; D006207:Half-Life; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology / Q000378:metabolism*; D006801:Humans; D007223:Infant; D008297:Male
chemical_list: D005169:Factor VIII